Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]

Carl D. Atkins; Mark Rosenthal; Alfredo Berruti; Marcello Tucci; Carlo Terrone; Roberto Mario Scarpa; Alberto Angeli; Luigi Dogliotti; Fred Saad; Donald M. Gleason; Robin Murray; J. Allen Goas; Bee Chen

doi:10.1093/jnci/95.4.332

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]

Carl D. Atkins, Mark Rosenthal, Alfredo Berruti, Marcello Tucci, Carlo Terrone, Roberto Mario Scarpa, Alberto Angeli, Luigi Dogliotti, Fred Saad, Donald M. Gleason, Robin Murray, J. Allen Goas, Bee Chen

Risultato della ricerca: Contributo su rivista › Lettera › peer review

Lingua originale	Inglese
pagine (da-a)	332-333
Numero di pagine	2
Rivista	Journal of the National Cancer Institute
Volume	95
Numero di pubblicazione	4
DOI	https://doi.org/10.1093/jnci/95.4.332
Stato di pubblicazione	Pubblicato - 19 feb 2003
Pubblicato esternamente	Sì

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1093/jnci/95.4.332

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Atkins, C. D., Rosenthal, M., Berruti, A., Tucci, M., Terrone, C., Scarpa, R. M., Angeli, A., Dogliotti, L., Saad, F., Gleason, D. M., Murray, R., Goas, J. A., & Chen, B. (2003). Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]. Journal of the National Cancer Institute, 95(4), 332-333. https://doi.org/10.1093/jnci/95.4.332

@article{44cdafebd6694381a3c84005105471f3,

title = "Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]",

author = "Atkins, {Carl D.} and Mark Rosenthal and Alfredo Berruti and Marcello Tucci and Carlo Terrone and Scarpa, {Roberto Mario} and Alberto Angeli and Luigi Dogliotti and Fred Saad and Gleason, {Donald M.} and Robin Murray and Goas, {J. Allen} and Bee Chen",

year = "2003",

month = feb,

day = "19",

doi = "10.1093/jnci/95.4.332",

language = "English",

volume = "95",

pages = "332--333",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "4",

}

Atkins, CD, Rosenthal, M, Berruti, A, Tucci, M, Terrone, C, Scarpa, RM, Angeli, A, Dogliotti, L, Saad, F, Gleason, DM, Murray, R, Goas, JA & Chen, B 2003, 'Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]', Journal of the National Cancer Institute, vol. 95, n. 4, pagg. 332-333. https://doi.org/10.1093/jnci/95.4.332

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]. / Atkins, Carl D.; Rosenthal, Mark; Berruti, Alfredo et al.
In: Journal of the National Cancer Institute, Vol. 95, N. 4, 19.02.2003, pag. 332-333.

Risultato della ricerca: Contributo su rivista › Lettera › peer review

TY - JOUR

T1 - Re

T2 - A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2]

AU - Atkins, Carl D.

AU - Rosenthal, Mark

AU - Berruti, Alfredo

AU - Tucci, Marcello

AU - Terrone, Carlo

AU - Scarpa, Roberto Mario

AU - Angeli, Alberto

AU - Dogliotti, Luigi

AU - Saad, Fred

AU - Gleason, Donald M.

AU - Murray, Robin

AU - Goas, J. Allen

AU - Chen, Bee

PY - 2003/2/19

Y1 - 2003/2/19

UR - http://www.scopus.com/inward/record.url?scp=0037453895&partnerID=8YFLogxK

U2 - 10.1093/jnci/95.4.332

DO - 10.1093/jnci/95.4.332

M3 - Letter

SN - 0027-8874

VL - 95

SP - 332

EP - 333

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 4

ER -